So if a thyroid medication has 38 micrograms of T4, you can appreciate how tiny an amount that is. That is why there are fillers. Now, at first the manufacturers used cornstarch and other problematic fillers. Some people still have undesirable reactions to the fillers.o now there is absolutely no difference in standardization between synthetic and natural forms of thyroid, as long as the manufacturers are adhering to the standards. In fact, the USP standard allows a 10% variation in T4 and 10% variation in T3 in the manufacture of thyroid medications.
The value chain is a systematic approach to examining the development of competitive advantage and was created by M. E. Porter in his books on Competitive Advantage (1980 and 1985).
the impact of autonomous and non-autonomous elements of the value chain on the corporate strategy of small and medium sized enterprises engaged in outsourcing. The model leans toward better utilization and better management of the components of the value chain under turbulent economic conditions.